|
1
|
World Health Organization. Classification
of Tumors of Haematopoietic and Lymphoid Tissues. IARC Press; Lyon:
2008
|
|
2
|
Nogai H, Dörken B and Lenz G: Pathogenesis
of non-Hodgkin's lymphoma. J Clin Oncol. 29:1803–1811. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alizadeh AA, Eisen MB, Davis RE, Ma C,
Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al:
Distinct types of diffuse large B-cell lymphoma identified by gene
expression profiling. Nature. 403:503–511. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lenz G, Wright G, Dave SS, Xiao W, Powell
J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, et al;
Lymphoma/Leukemia Molecular Profiling Project. Stromal gene
signatures in large-B-cell lymphomas. N Engl J Med. 359:2313–2323.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jozkowicz A, Was H and Dulak J: Heme
oxygenase-1 in tumors: Is it a false friend? Antioxid Redox Signal.
9:2099–2117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Foresti R, Clark JE, Green CJ and
Motterlini R: Thiol compounds interact with nitric oxide in
regulating heme oxygenase-1 induction in endothelial cells.
Involvement of superoxide and peroxynitrite anions. J Biol Chem.
272:18411–18417. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stuhlmeier KM: Activation and regulation
of Hsp32 and Hsp70. Eur J Biochem. 267:1161–1167. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Terry CM, Clikeman JA, Hoidal JR and
Callahan KS: Effect of tumor necrosis factor-alpha and
interleukin-1 alpha on heme oxygenase-1 expression in human
endothelial cells. Am J Physiol. 274:H883–H891. 1998.PubMed/NCBI
|
|
9
|
Miyazaki T, Kirino Y, Takeno M, Samukawa
S, Hama M, Tanaka M, Yamaji S, Ueda A, Tomita N, Fujita H, et al:
Expression of heme oxygenase-1 in human leukemic cells and its
regulation by transcriptional repressor Bach1. Cancer Sci.
101:1409–1416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Furfaro AL, Piras S, Passalacqua M,
Domenicotti C, Parodi A, Fenoglio D, Pronzato MA, Marinari UM,
Moretta L, Traverso N, et al: HO-1 up-regulation: A key point in
high-risk neuroblastoma resistance to bortezomib. Biochim Biophys
Acta. 1842:613–622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee SE, Yang H, Jeong SI, Jin YH, Park CS
and Park YS: Induction of heme oxygenase-1 inhibits cell death in
crotonaldehyde-stimulated HepG2 cells via the PKC-δ-p38-Nrf2
pathway. PLoS One. 7:e416762012. View Article : Google Scholar
|
|
12
|
Zhang L, Liu YL, Chen GX, Cui B, Wang JS,
Shi YL, Li LP and Guo XB: Heme oxygenase-1 promotes Caco-2 cell
proliferation and migration by targeting CTNND1. Chin Med J (Engl).
126:3057–3063. 2013.
|
|
13
|
Kongpetch S, Kukongviriyapan V, Prawan A,
Senggunprai L, Kukongviriyapan U and Buranrat B: Crucial role of
heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to
chemotherapeutic agents. PLoS One. 7:e349942012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mayerhofer M, Gleixner KV, Mayerhofer J,
Hoermann G, Jaeger E, Aichberger KJ, Ott RG, Greish K, Nakamura H,
Derdak S, et al: Targeting of heat shock protein 32 (Hsp32)/heme
oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: A
novel approach to overcome resistance against imatinib. Blood.
111:2200–2210. 2008. View Article : Google Scholar
|
|
15
|
Ma D, Fang Q, Wang P, Gao R, Sun J, Li Y,
Hu XY and Wang JS: Downregulation of HO-1 promoted apoptosis
induced by decitabine via increasing p15INK4B promoter
demethylation in myelodysplastic syndrome. Gene Ther. 22:287–296.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei S, Wang Y, Chai Q, Fang Q, Zhang Y and
Wang J: Potential crosstalk of Ca2+-ROS-dependent
mechanism involved in apoptosis of Kasumi-1 cells mediated by heme
oxygenase-1 small interfering RNA. Int J Oncol. 45:2373–2384.
2014.PubMed/NCBI
|
|
17
|
Ma D, Fang Q, Wang P, Gao R, Wu W, Lu T,
Cao L, Hu X and Wang J: Induction of heme oxygenase-1 by
Na+-H+ exchanger 1 protein plays a crucial
role in imatinib-resistant chronic myeloid leukemia cells. J Biol
Chem. 290:12558–12571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang P, Ma D, Wang J, Fang Q, Gao R, Wu W,
Lu T and Cao L: Silencing HO-1 sensitizes SKM-1 cells to apoptosis
induced by low concentration 5-azacytidine through enhancing p16
demethylation. Int J Oncol. 46:1317–1327. 2015.PubMed/NCBI
|
|
19
|
Lin X, Fang Q, Chen S, Zhe N, Chai Q, Yu
M, Zhang Y, Wang Z and Wang J: Heme oxygenase-1 suppresses the
apoptosis of acute myeloid leukemia cells via the JNK/c-JUN
signaling pathway. Leuk Res. 39:544–552. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Davis RE, Brown KD, Siebenlist U and
Staudt LM: Constitutive nuclear factor kappaB activity is required
for survival of activated B cell-like diffuse large B cell lymphoma
cells. J Exp Med. 194:1861–1874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Compagno M, Lim WK, Grunn A, Nandula SV,
Brahmachary M, Shen Q, Bertoni F, Ponzoni M, Scandurra M, Califano
A, et al: Mutations of multiple genes cause deregulation of
NF-kappaB in diffuse large B-cell lymphoma. Nature. 459:717–721.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Davis RE, Ngo VN, Lenz G, Tolar P, Young
RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, et al:
Chronic active B-cell-receptor signalling in diffuse large B-cell
lymphoma. Nature. 463:88–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lenz G and Staudt LM: Aggressive
lymphomas. N Engl J Med. 362:1417–1429. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ngo VN, Davis RE, Lamy L, Yu X, Zhao H,
Lenz G, Lam LT, Dave S, Yang L, Powell J, et al: A loss-of-function
RNA interference screen for molecular targets in cancer. Nature.
441:106–110. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lam LT, Davis RE, Pierce J, Hepperle M, Xu
Y, Hottelet M, Nong Y, Wen D, Adams J, Dang L, et al: Small
molecule inhibitors of IkappaB kinase are selectively toxic for
subgroups of diffuse large B-cell lymphoma defined by gene
expression profiling. Clin Cancer Res. 11:28–40. 2005.PubMed/NCBI
|
|
26
|
Lavrovsky Y, Schwartzman ML, Levere RD,
Kappas A and Abraham NG: Identification of binding sites for
transcription factors NF-kappa B and AP-2 in the promoter region of
the human heme oxygenase 1 gene. Proc Natl Acad Sci USA.
91:5987–5991. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kurata S, Matsumoto M, Tsuji Y and
Nakajima H: Lipopolysaccharide activates transcription of the heme
oxygenase gene in mouse M1 cells through oxidative activation of
nuclear factor kappa B. Eur J Biochem. 239:566–571. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin CC, Chiang LL, Lin CH, Shih CH, Liao
YT, Hsu MJ and Chen BC: Transforming growth factor-beta1 stimulates
heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways
in human lung epithelial cells. Eur J Pharmacol. 560:101–109. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Q, Guo Y, Ou Q, Cui C, Wu WJ, Tan W,
Zhu X, Lanceta LB, Sanganalmath SK, Dawn B, et al: Gene transfer of
inducible nitric oxide synthase affords cardioprotection by
upregulating heme oxygenase-1 via a nuclear
factor-{kappa}B-dependent pathway. Circulation. 120:1222–1230.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rushworth SA, Zaitseva L, Murray MY, Shah
NM, Bowles KM and MacEwan DJ: The high Nrf2 expression in human
acute myeloid leukemia is driven by NF-κB and underlies its
chemoresistance. Blood. 120:5188–5198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ogborne RM, Rushworth SA and O'Connell MA:
Alpha-lipoic acid-induced heme oxygenase-1 expression is mediated
by nuclear factor erythroid 2-related factor 2 and p38
mitogen-activated protein kinase in human monocytic cells.
Arterioscler Thromb Vasc Biol. 25:2100–2105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rushworth SA, Chen XL, Mackman N, Ogborne
RM and O'Connell MA: Lipopolysaccharide-induced heme oxygenase-1
expression in human monocytic cells is mediated via Nrf2 and
protein kinase C. J Immunol. 175:4408–4415. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ai ZL, Zhu CH, Min M, Wang J, Lan CH, Fan
LL, Sun WJ and Chen DF: The role of hepatic liver X receptor α- and
sterol regulatory element binding protein-1c-mediated lipid
disorder in the pathogenesis of non-alcoholic steatohepatitis in
rats. J Int Med Res. 39:1219–1229. 2011. View Article : Google Scholar
|
|
34
|
Scott DW, Wright GW, Williams PM, Lih CJ,
Walsh W, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, et
al: Determining cell-of-origin subtypes of diffuse large B-cell
lymphoma using gene expression in formalin-fixed paraffin-embedded
tissue. Blood. 123:1214–1217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gandini NA, Fermento ME, Salomón DG,
Blasco J, Patel V, Gutkind JS, Molinolo AA, Facchinetti MM and
Curino AC: Nuclear localization of heme oxygenase-1 is associated
with tumor progression of head and neck squamous cell carcinomas.
Exp Mol Pathol. 93:237–245. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Miyata Y, Kanda S, Mitsunari K, Asai A and
Sakai H: Heme oxygenase-1 expression is associated with tumor
aggressiveness and outcomes in patients with bladder cancer: A
correlation with smoking intensity. Transl Res. 164:468–476. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gerdes J, Schwab U, Lemke H and Stein H:
Production of a mouse monoclonal antibody reactive with a human
nuclear antigen associated with cell proliferation. Int J Cancer.
31:13–20. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Szczuraszek K, Mazur G, Jeleń M, Dziegiel
P, Surowiak P and Zabel M: Prognostic significance of Ki-67 antigen
expression in non-Hodgkin's lymphomas. Anticancer Res.
28A:1113–1118. 2008.
|
|
39
|
Miller TP, Grogan TM, Dahlberg S, Spier
CM, Braziel RM, Banks PM, Foucar K, Kjeldsberg CR, Levy N, Nathwani
BN, et al: Prognostic significance of the Ki-67-associated
proliferative antigen in aggressive non-Hodgkin's lymphomas: A
prospective Southwest Oncology Group trial. Blood. 83:1460–1466.
1994.PubMed/NCBI
|
|
40
|
Katzenberger T, Petzoldt C, Höller S,
Mäder U, Kalla J, Adam P, Ott MM, Müller-Hermelink HK, Rosenwald A
and Ott G: The Ki67 proliferation index is a quantitative indicator
of clinical risk in mantle cell lymphoma. Blood. 107:34072006.
View Article : Google Scholar : PubMed/NCBI
|
